세계의 구내염 치료 시장 규모는 2024년에 19억 7,000만 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 25억 5,000만 달러에 달하며, 2025-2033년에 2.74%의 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 이 시장은 주로 구강 위생 문제의 발생률 증가, 치료 옵션에 대한 인식 증가, 시판 중인 치료제에 대한 수요 증가로 인해 크게 성장하고 있습니다. 제약 제제의 발전, 의료 서비스 접근성 확대, 구내염 치료를 위한 속효성 진통제에 대한 소비자 선호도도 시장 성장에 긍정적으로 기여하고 있습니다.
제형 혁신
각 업체들은 빠른 완화와 치유를 원하는 소비자의 요구에 부응하기 위해 속효성 구내염 치료제를 개발하고 있습니다. 이러한 혁신에는 통증을 최소화하고 몇 시간 내에 회복을 가속화하도록 설계된 국소용 젤, 구강 세정제, 약용 패치 등이 포함됩니다. 첨단 제제는 즉각적인 흡수 또는 서방형으로 표적화된 작용을 제공함으로써 효과가 오래 지속되도록 하는 데 초점을 맞추었습니다. 이러한 추세는 소비자의 편의성에 대한 기대에 힘입어, 적용이 간편하면서도 빠른 완화를 제공하는 제품에 대한 요구가 증가하고 있습니다. 처방전 없이도 빠른 치료가 가능한 빠른 솔루션은 바쁜 현대인의 라이프스타일에도 매력적으로 다가올 수 있습니다. 또한 2024년 European Journal of Pharmaceutics and Biopharmaceutics에 게재된 논문에 따르면 혁신적인 유제놀과 붕사를 기반으로 한 구강내 분산성 필름(ODF)의 개발은 구내염을 포함한 구강 질환을 치료하는 ODF는 초박형, 스탬프 크기, 휴대용, 환자 친화적, 친수성 필름으로 물이나 삼킬 필요 없이 혀나 뺨에 몇 초 만에 용해 및 분해되는 초박형, 스탬프 크기, 환자 친화적, 친수성 필름으로 기존 방식에 대한 대안으로 떠오르고 있습니다. 이 투여법은 특히 소아, 노인, 연하장애가 있는 특수한 환자층에 널리 보급되어 있습니다.
E-Commerce 채널의 성장
더 많은 소비자들이 편리함을 위해 온라인 쇼핑으로 이동함에 따라 구내염 치료제의 E-Commerce 채널의 성장이 가속화되고 있습니다. 온라인 플랫폼은 지역 약국에서 구할 수 없는 다양한 천연 의약품, OTC 의약품, 특수 치료제를 포함한 다양한 품목을 제공합니다. 소비자들은 가격 비교, 리뷰 검색, 빠른 제품 수령이 용이하고, 할인 및 정기 구매 서비스를 받을 수 있다는 이점이 있습니다. 또한 전자 약국 및 디지털 건강 플랫폼의 등장은 이러한 치료법의 가용성과 접근성 향상에 기여하여 시장에서의 온라인 판매를 촉진하고 있습니다. 예를 들어 IMARC에 따르면 세계 전자 약국 시장 규모는 2023년 942억 달러에 달할 것으로 예측됩니다. 향후 IMARC 그룹은 이 시장이 2032년까지 3,141억 달러에 달하고, 2024-2032년까지 14.32%의 연평균 성장률(CAGR)을 보일 것으로 예상하고 있습니다. 또한 아마존 약국은 2024년 6월 메디케어 보험 가입자에게도 정기 구매 서비스를 확대할 계획이라고 발표했습니다. 이를 통해 5,000만 명 이상의 메디케어 수혜자가 아마존 파머시(Amazon Pharmacy)의 정액제 처방전 서비스인 RxPass를 이용할 수 있게 됩니다.
천연 및 허브 제품으로의 전환
소비자들은 합성 약품의 잠재적인 부작용에 대한 우려로 인해 구내염 치료를 위해 천연 소재와 허브 제품으로 눈을 돌리고 있습니다. 알로에베라, 카모마일, 감초와 같은 성분은 진정 및 치유 효과가 있으며, 선호되고 있습니다. 이러한 변화의 배경에는 사람들이 건강 지향적인 라이프스타일에 따라 유기농, 화학물질이 없는 솔루션을 선호하고 웰빙에 대한 관심이 높아지면서 웰빙에 대한 관심이 높아졌기 때문으로 분석됩니다. 이러한 치료법에 대한 수요 증가는 이러한 추세에 대응하기 위해 식물 유래 제품을 개발하는 기업을 자극하고 있으며, 천연 대체품이 시장에 널리 보급되고 있습니다. 구내염 치료제 시장 개요에 따르면 이러한 자연 요법과 허브 요법에 대한 소비자의 선호도가 높아짐에 따라 더 많은 기업이 유기농 및 화학 물질이 없는 솔루션에 대한 수요 증가에 대응하기 위해 식물 기반 제제에 투자함으로써 큰 성장을 가속할 것으로 예측됩니다. 큰 성장을 가속할 것으로 예측됩니다. 예를 들어 2023년 11월 UGM 치과대학 학생들은 과일 껍질에서 구내염 치료를 위한 친환경 효소를 개발했다고 발표했습니다. 연구팀은 다양한 과일과 식물의 껍질을 친환경 효소로 가공해 구내염의 치유를 촉진하는 것을 목표로 했습니다. 쥐를 대상으로 한 실험실 실험에서 에코효소 패치가 구내염 상처의 염증 세포를 감소시킨다는 유망한 결과를 얻었습니다. 연구는 아직 초기 단계이며, 동물 실험에 머물러 있지만, 인간에 대한 사용의 안전성과 유효성을 보장하기 위해서는 더 종합적인 연구가 필요합니다.
The global mouth ulcer treatment market size reached USD 1.97 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.55 Billion by 2033, exhibiting a growth rate (CAGR) of 2.74% during 2025-2033. The market is experiencing significant growth mainly driven by rising incidences of oral health issues, an increased awareness of treatment options and the growing demand for over-the-counter remedies. Advancements in pharmaceutical formulations, expanding healthcare access and consumer preference for fast-acting, pain-relief products to treat mouth ulcers are also contributing positively to the market growth.
Innovation in Formulations
Companies are developing fast-acting mouth ulcer treatments to address the consumer demand for quicker relief and healing. These innovations include topical gels, oral rinses, and medicated patches designed to minimize pain and accelerate recovery within hours. Advanced formulations focus on delivering targeted action through immediate absorption or sustained release, providing long-lasting effects. This trend is driven by consumer expectations for convenience, with products that offer swift relief while being easy to apply. These rapid solutions are also appealing in busy lifestyles where quick treatment without the need for prescriptions is highly valued. Furthermore, according to an article published in the European Journal of Pharmaceutics and Biopharmaceutics in 2024, the development of innovative eugenol and borax-based orodispersible films (ODFs) have emerged as the preferred alternative to traditional methods of treating oral diseases, including mouth ulcers, with a much more efficient results. ODFs are ultra-thin, stamp-sized, portably-used, patient-friendly, and hydrophilic films that dissolve and disintegrate within seconds on the tongue or buccal area without the need of water or swallowing. This administration is particularly prevalent among pediatric, geriatric, and special patient populations who have dysphagia.
Growth in E-Commerce Channels
Growth in e-commerce channels for mouth ulcer treatments is accelerating as more consumers shift toward online shopping for convenience. Online platforms offer a wider selection of products, including various natural, OTC, and specialized treatments, which may not be available in local pharmacies. Consumers benefit from the ease of comparing prices, reading reviews, and receiving products quickly, often with discounts or subscription services. Additionally, the rise of e-pharmacies and digital health platforms has contributed to the increased availability and accessibility of these treatments, boosting online sales in the market. For instance, according to IMARC, the global e-pharmacy market size reached US$ 94.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 314.1 Billion by 2032, exhibiting a growth rate (CAGR) of 14.32% during 2024-2032. Furthermore, Amazon Pharmacy announced in June 2024 that it intends to expand its subscription service to enrollees of Medicare insurance plans. The expansion will be available to more than 50 million Medicare beneficiaries, who will have access to RxPass, Amazon Pharmacy's subscription prescription service
Shift Towards Natural and Herbal Products
Consumers are increasingly turning to natural and herbal products for mouth ulcer treatment due to concerns about the potential side effects of synthetic medications. Ingredients like aloe vera, chamomile, and licorice are favored for their soothing and healing properties. This shift is driven by a broader focus on wellness, as people prefer organic and chemical-free solutions that align with health-conscious lifestyles. The growing demand for such treatments is encouraging companies to develop more plant-based products that cater to this trend, making natural alternatives widely available across the market. According to the mouth ulcer treatment market overview, this rising consumer preference for natural and herbal remedies is expected to drive significant growth, with more companies investing in plant-based formulations to meet the increasing demand for organic, chemical-free solutions. For instance, in November 2023, UGM Dentistry students announced the development of eco-enzymes from fruit peels for mouth ulcer treatment. The team processed peels from various fruits and plants into eco-enzymes, aiming to accelerate mouth ulcer healing. Laboratory research on rats showed promising results, with the eco-enzyme patch reducing inflammatory cells in mouth ulcer wounds. While the research is in early stages and tested only on animals, further comprehensive studies are required to ensure its safety and efficacy for human use.
Gel accounts for the majority of the market share
According to mouth ulcer treatment market report, gel dominate the market due to their fast-acting and targeted relief. Their easy application and ability to form a protective barrier over the ulcer make them highly effective in soothing pain and accelerating healing. Gels often contain active ingredients like antiseptics, pain relievers, and anti-inflammatory agents, providing comprehensive treatment in a single application. Their ability to stay localized at the site of the ulcer allows for longer-lasting relief compared to other forms, such as mouthwashes or lozenges. This convenience and effectiveness have led to their widespread preference among consumers.
Corticosteroids holds the largest share of the industry
Corticosteroids hold the largest share of the mouth ulcer treatment industry due to their powerful anti-inflammatory and immunosuppressive properties. These medications effectively reduce swelling, pain, and irritation associated with mouth ulcers, promoting faster healing. Corticosteroids are often prescribed for severe or recurrent cases of ulcers, such as aphthous stomatitis, where over-the-counter treatments may be less effective. Their ability to target the underlying inflammation makes them a preferred choice among healthcare professionals. Additionally, advancements in topical corticosteroid formulations, like gels and ointments, have improved patient compliance by offering localized relief with minimal systemic side effects. These factors are creating a positive mouth ulcer treatment market outlook, driving the demand for corticosteroid-based products due to their efficacy in managing severe ulcer cases.
Aphthous Stomatitis represents the leading market segment
Aphthous stomatitis, commonly known as canker sores, represents the leading segment in the mouth ulcer treatment market due to its high prevalence among individuals worldwide. This condition is characterized by recurrent, painful ulcers in the mouth, often triggered by stress, injury, or nutritional deficiencies. The demand for effective treatments, such as corticosteroids, gels, and antiseptic mouthwashes, is high as patients seek fast relief from discomfort and accelerated healing. The chronic and recurrent nature of aphthous stomatitis drives the consistent demand for both over-the-counter and prescription treatments. The mouth ulcer treatment market dynamics are further influenced by the need for innovative and accessible solutions to manage the chronic and recurrent nature of aphthous stomatitis, leading to continuous advancements in treatment options and increased competition among pharmaceutical companies. According to an article published in May 2023 by National Library of Medicine, approximately 25% of the global population is affected by recurrent aphthous stomatitis (RAS), a common oral mucosal disease. Factors such as genetics, nutritional deficiencies, stress, and immune dysfunction contribute to the condition. This high prevalence underscores the significant demand for effective treatments and preventive solutions in the market. As a result, pharmaceutical companies are focusing on developing targeted therapies that address the underlying causes of RAS while minimizing recurrence and improving patient outcomes.
North America leads the market, accounting for the largest mouth ulcer treatment market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, Latin America. According to the report, North America represents the largest regional market for mouth ulcer treatment.
North America leads the global mouth ulcer treatment market, accounting for the largest share due to the region's high awareness of oral health and access to advanced healthcare services. The prevalence of conditions like aphthous stomatitis and other oral ulcers is significant, driving the demand for both over-the-counter and prescription treatments. The region's well-established pharmaceutical industry supports the development and availability of effective treatments, such as corticosteroids, gels, and mouthwashes. Additionally, the focus on research and innovation, along with favorable healthcare reimbursement policies, boosts market growth. The increasing preference for fast-acting, pain-relief products further strengthens North America's leadership in this market. According to mouth ulcer treatment market forecast, North America is expected to continue to lead, with steady growth driven by ongoing advancements in treatment options, rising demand for innovative therapies, and increasing awareness of oral health management. For instance, in November 2023, MidAmerica Pharmaceuticals introduced Kourzeq(TM), a new FDA-approved dental paste for treating canker sores. The paste, containing triamcinolone acetonide, is designed to provide temporary relief and adjunctive treatment for oral inflammatory and ulcerative lesions. Available exclusively through telehealth via BeyondMD, Kourzeq aims to make a positive impact on those suffering from canker sores.